Zhong et al. also found that along with other ferroptosis-related genes found to be differentially expressed in AML patients, GPX4 overexpression was again associated with poor prognosis in other publicly available cohorts [112]. This evidence concerns the gene GPX4 and acute myeloid leukemia.